LONG NAGOMI™ PMCF STUDY

Inclusion Criteria: * Patients who meet ALL inclusion criteria will be included: * Patients aged ≥ 18 years AND; * Patients who according to standard practice of the hospital are amenable to PCI as indicated and considered adequate according to the European clinical practice guidelines on coronary revascularization AND; * Patients with at least one lesion fulfilling the "long lesion criteria" suitable for a single stent approach AND; * Patients who have been informed of the characteristics of the study and have provided written informed consent AND; * Intention to treat all lesions with the Ultimaster Nagomi™ stent Exclusion Criteria: * Patients must not meet any of the following exclusion criteria: * Patients who expressly decline to participate in the study. * Pregnant or breastfeeding women. * Patients with acute coronary syndrome (ACS) under conditions of cardiogenic shock (Killip class 4). * Patients with contraindications or hypersensitivity to sirolimus. * Patients with a life expectancy of less than 2 years. * Patients in whom any surgery requiring general anesthesia is planned, comorbidity or indication likely necessitating the discontinuation of dual anti-platelet therapy before the recommended duration of dual anti-platelet therapy per the ESC or national guidelines. * Patients included in other clinical trials that did not reach the primary objective.